Geldanamycin-Induced Osteosarcoma Cell Death Is Associated with Hyperacetylation and Loss of Mitochondrial Pool of Heat Shock Protein 60 (Hsp60)-Reference-Cited by-同舟云学术

Geldanamycin-Induced Osteosarcoma Cell Death Is Associated with Hyperacetylation and Loss of Mitochondrial Pool of Heat Shock Protein 60 (Hsp60)

Published:2013-08-28 Issue:8 Volume:8 Page:e71135
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gorska Magdalena,Marino Gammazza Antonella,Zmijewski Michal Aleksander,Campanella Claudia,Cappello Francesco,Wasiewicz Tomasz,Kuban-Jankowska Alicja,Daca Agnieszka,Sielicka Alicja,Popowska Urszula,Knap Narcyz,Antoniewicz Jakub,Wakabayashi Takashi,Wozniak Michal

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. The molecular pathogenesis of osteosarcoma: a review;ML Broadhead;Sarcoma,2011

2. Osteosarcoma: a review of diagnosis, management, and treatment strategies;DS Geller;Clinical advances in hematology & oncology: H&O,2010

3. Therapy for osteosarcoma: where do we go from here?;AJ Chou;Paediatric drugs,2008

4. New targets and approaches in osteosarcoma;J Gill;Pharmacology & therapeutics,2013

5. Heat shock proteins in oncology: Diagnostic biomarkers or therapeutic targets?;AA Khalil;Biochimica Et Biophysica Acta-Reviews on Cancer,2011

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antagonistic interaction of HSP90 inhibitor XL-888 and 5-FU combination treatment in breast cancer cells;International Advanced Researches and Engineering Journal;2024-08-07

2. Quantitative analysis of the lysine acetylome reveals the role of SIRT3-mediated HSP60 deacetylation in suppressing intracellular Mycobacterium tuberculosis survival;Microbiology Spectrum;2024-08-06

3. Mitochondrial Chaperone Code: Just warming up;Cell Stress and Chaperones;2024-06

4. Heat Shock Proteins, a Double-Edged Sword: Significance in Cancer Progression, Chemotherapy Resistance and Novel Therapeutic Perspectives;Cancers;2024-04-14

5. Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors;Cancers;2022-12-30